Marco Vecchia
Direktor/Vorstandsmitglied bei Cheshire Healthcare Ltd.
Ursprung des Netzwerks ersten Grades von Marco Vecchia
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 19 | |
CHIESI Farmaceutici SpA
 CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Opocrin SpA
 Opocrin SpA Pharmaceuticals: MajorHealth Technology Opocrin SpA engages in the manufacture and marketing of active ingredients for the pharmaceutical industry. Its products include Collagen Gel, Sodium and Calcium Heparin, Iron Complexes, Parnaparin, and Pulmonary Surfactant. The company was founded by Pietro Bianchini in 1964 and is headquartered in Modena, Italy.
7
| Private Company | Pharmaceuticals: Major | 7 |
Chiesi SA (Belgium)
 Chiesi SA (Belgium) Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Chiesi SA (Belgium) is a Belgian pharmaceutical company specializing in the treatment of respiratory diseases, neonatology, rare diseases, and special care. Chiesi SA (Belgium is based in Machelen, BE. The company's focus on innovation and patient care has led to collaborations with other organizations, such as Affibody, and the development of new treatments for rare diseases. Chiesi SA (Belgium is committed to sustainability and participates in events such as Climbing for Life. The company was founded in 2010 by Giacomo Chiesi, and the CEO is Alberto Chiesi.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Chiesi Ltd.
 Chiesi Ltd. Electronic Equipment/InstrumentsElectronic Technology Chiesi Ltd. develops and markets respiratory products. It offers medicines for the treatment of respiratory disease. The company was founded on June 18, 1987 and is headquartered in Manchester, the United Kingdom.
6
| Subsidiary | Electronic Equipment/Instruments | 6 |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Chiesi Pharmaceuticals, Inc.
2
| Private Company | 2 | |
Chiesi España SA
 Chiesi España SA Pharmaceuticals: MajorHealth Technology Chiesi España SA manufactures and distributes pharmaceutical products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation, and neonatology. The firm produces respiratory dosage forms such as metered-dose inhalers and sterile unit dose vials for nebulisation. It also provides solutions for the treatment of asthma and chronic obstructive pulmonary diseases. The company is headquartered in Barcelona, Spain.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Chiesi Pharmaceuticals BV
 Chiesi Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Chiesi Pharmaceuticals BV provides research, development and sale of medical products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation and neonatology. The company is headquartered in Rijswijk, the Netherlands.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Chiesi Hellas Pharmaceuticals SA
 Chiesi Hellas Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Chiesi Hellas Pharmaceuticals SA provides research, development and sale of medicinal products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation and neonatology. The company produces respiratory dosage forms such as metered-dose inhalers and sterile unit dose vials for nebulisation. It offers solutions for the treatment of asthma and chronic obstructive pulmonary disease. The company is headquartered in Vrilissa, Greece.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Marco Vecchia
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| HERON THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Chief Operating Officer | |
| GENERAL MILLS, INC. | Food: Major Diversified | General Counsel | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
United States Surgical Corp.
 United States Surgical Corp. Medical SpecialtiesHealth Technology United States Surgical Corp. engages in the manufacture of wound closure products and surgical devices. It produces tools used in surgery including staplers, sutures, laparoscopic instruments, cardiovascular surgical products and electrosurgical devices. The company was founded in 1964 and is headquartered in North Haven, CT. | Medical Specialties | Corporate Officer/Principal | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member | |
TYRX, Inc.
 TYRX, Inc. Electronic Equipment/InstrumentsElectronic Technology TYRX, Inc. designs and manufactures medical-pharmaceutical combination devices. The firm commercializes implantable combination drug and device products focused on infection control including the AIGISRx Antibacterial Envelope, designed to reduce surgical site infections associated with cardiac implantable electronic devices (CIEDs). Its AIGISRx products contain the antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by pathogens responsible for the majority of CIED infections, including superbugs such as methicillin-resistant S. aureus (MRSA). The company was founded in 1998 by Satish Pulapura and Arikha Moses and is headquartered in Monmouth Junction, NJ. | Electronic Equipment/Instruments | Director/Board Member | |
Premier Research Group Ltd.
 Premier Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Premier Research Group Ltd. provides contract research services to pharmaceutical industry. It engages in analgesics, neuroscience, medical devices, rare diseases and pediatrics. The company offers pediatric experience with both familiar and extremely rare childhood illnesses, including work at PICUs, NICUs, clinics, ERs and neonatal studies. Premier Research Group was founded in 2002 and is headquartered in Wokingham, the United Kingdom. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chief Executive Officer Chairman Director of Finance/CFO Public Communications Contact General Counsel | |
PreCision Dermatology, Inc.
 PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology PreCision Dermatology, Inc. developed skincare therapies. It offered pharmaceutical products for skin barrier restoration, dermatoses, rosacea, acne, seborrheic dermatitis, and scaling associated with hyperkeratotic skin. The company was founded by Jeffrey M. Nugent in 2010 and was headquartered in Cumberland, RI. | Pharmaceuticals: Major | Founder | |
Apple Communications, Inc.
 Apple Communications, Inc. Wireless TelecommunicationsCommunications Apple Communications, Inc. provides radio-telephone communication services. It also offers transportation and other communication services. The company is located in Chicago, IL. | Wireless Telecommunications | Corporate Officer/Principal | |
NETg, Inc.
 NETg, Inc. Internet Software/ServicesTechnology Services NETg, Inc. provides integrated corporate learning solutions. The company offers services to the individuals, businesses, and institutions. It also provides learning management software, courseware development applications, skills management software, and other tools for managing organizational training programs. NETg was founded in 1968 and is headquartered in Scottsdale, AZ. | Internet Software/Services | Corporate Officer/Principal | |
| Lawrence University | College/University | Undergraduate Degree | |
| Moravian College | College/University | Undergraduate Degree | |
Warburg Pincus & Company US LLC
 Warburg Pincus & Company US LLC Investment ManagersFinance Warburg Pincus & Company US LLC engages in the provision of investment services. The company is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal | |
| The Pennsylvania State University | College/University | Undergraduate Degree Doctorate Degree | |
| University of Wisconsin | College/University | Graduate Degree | |
| INSEAD | College/University | Masters Business Admin | |
| University of Connecticut | College/University | Undergraduate Degree Masters Business Admin | |
Zymenex A/S
 Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Biotechnology | Director/Board Member Chairman | |
Forest Laboratories Europe
 Forest Laboratories Europe Pharmaceuticals: MajorHealth Technology Forest Laboratories Europe manufactures prescription and OTC medications for ailments. The company also manufactures infant and elderly care products targeted for use by nurses and midwives, including Sudocreme, a diaper rash ointment and Fletchers' enema products. The company was founded in 1938 and is located in Bexley, UK. | Pharmaceuticals: Major | Chief Executive Officer | |
| US Securities & Exchange Commission | Investment Banks/Brokers | General Counsel | |
| OCATA THERAPEUTICS INC | Pharmaceuticals: Major | Chairman | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Chief Operating Officer Chief Executive Officer | |
Biovail Pharmaceuticals LLC
 Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Biovail Pharmaceuticals, Inc. researches and develops pharmaceutical medicines. The company products include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Oncology Development Partners LLC
 Oncology Development Partners LLC Miscellaneous Commercial ServicesCommercial Services Oncology Development Partners LLC is an American company that focuses on research and development in the field of oncology. | Miscellaneous Commercial Services | Director of Finance/CFO | |
National Association of Corporate Treasurers
 National Association of Corporate Treasurers Miscellaneous Commercial ServicesCommercial Services National Association of Corporate Treasurers provides financial services. The firm specializes in corporate finance, investor relations, employee benefits, cash management, financial risk, international currency management, credit and insurance. The company is headquartered in Reston, VA. | Miscellaneous Commercial Services | Director/Board Member | |
| Carolina Pharmaceuticals, Inc. | Chief Executive Officer Corporate Officer/Principal | ||
| Enlarged Group | Chief Executive Officer | ||
Astellas Pharma Co. Ltd.
 Astellas Pharma Co. Ltd. Medical DistributorsDistribution Services Part of Astellas Pharma, Inc., Astellas Pharma Co. Ltd. is a company headquartered in Dublin, Ireland. The firm wholesales medical products. | Medical Distributors | Chief Tech/Sci/R&D Officer | |
| Cedarledge Enterprises LLC | Chief Executive Officer | ||
| SYNTHORX, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| INNOCOLL HOLDINGS PLC | Pharmaceuticals: Major | Director/Board Member | |
| AMRYT PHARMA PLC | Pharmaceuticals: Major | Chairman Director of Finance/CFO Founder | |
| TERRASCEND CORP. | Agricultural Commodities/Milling | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigte Staaten | 39 |
| Vereinigtes Königreich | 4 |
| Dänemark | 3 |
| Italien | 2 |
| Frankreich | 2 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 7 |
| Technology Services | 6 |
| Commercial Services | 6 |
| Consumer Non-Durables | 4 |
Operativ
| Director/Board Member | 135 |
| Corporate Officer/Principal | 67 |
| Chief Executive Officer | 38 |
| Independent Dir/Board Member | 36 |
| President | 28 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Marios Fotiadis | 25 |
| Michael Heffernan | 23 |
| Laura Shawver | 18 |
| Craig Collard | 18 |
| Andrew Powell | 16 |
| Robert M. Stephan | 16 |
| David J. Price | 14 |
| Christopher George Codeanne | 14 |
| Joe Wiley | 14 |
| James A. Harper | 12 |
| Anton Giorgio Failla | 12 |
| Giuseppe Accogli | 12 |
| Ugo di Francesco | 11 |
| Rory Nealon | 11 |
| Steven M. Lutz | 8 |
- Börse
- Insiders
- Marco Vecchia
- Unternehmensverbindungen